Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07102550 · ClinicalTrials.gov registry record · Phase 2
Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue
A Phase 2 study of Liver Transplant, sponsored by Choon Hyuck David Kwon.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07102550 is a Phase 2 study of Liver Transplant that is actively recruiting participants, run by Choon Hyuck David Kwon. The registered enrollment target is 40 participants, below the 5,456-participant average among 19 other Liver Transplant trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07102550, a Phase 2 study of Liver Transplant, is actively recruiting participants, sponsored by Choon Hyuck David Kwon.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this single armed, non-randomized, pilot study is to demonstrate that placental tissue grafts are safe in living donor liver transplant and assess their impact on biliary outcomes in adults.
Conditions Studied
Interventions
- BIOLOGICAL MiMedx AmnioFix
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-10-29 |
| Est. Completion | 2027-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07102550
The ClinicalTrials.gov registry entry for NCT07102550 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,456-participant average among 19 other Liver Transplant trials with a reported enrollment target (99% lower). The listed sponsor is Choon Hyuck David Kwon, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Transplant appearing as the primary indexed condition, and to 1 intervention - of which MiMedx AmnioFix is the first listed.
NCT07102550 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07102550 about?
NCT07102550 is a clinical study titled "Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue". The goal of this single armed, non-randomized, pilot study is to demonstrate that placental tissue grafts are safe in living donor liver transplant and assess their impact on biliary outcomes in adults.
What is the current status of trial NCT07102550?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2024-10-29. Estimated completion is 2027-07.
What conditions does trial NCT07102550 study?
This clinical trial studies the following conditions: Liver Transplant.
What interventions are being tested in trial NCT07102550?
The interventions under investigation include: MiMedx AmnioFix (BIOLOGICAL).
Who is sponsoring clinical trial NCT07102550?
This trial is sponsored by Choon Hyuck David Kwon, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07102550 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
RECRUITING · Phase 2
-
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
RECRUITING · Phase 2
-
The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients
COMPLETED · Phase 2
-
Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine
COMPLETED · Phase 2
-
US National OCS Liver Perfusion (OLP) Registry
RECRUITING
-
Liver Transplant CGM
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.